Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19

scientific article published on 20 November 2020

Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.HELIYON.2020.E05558
P932PMC publication ID7679114
P698PubMed publication ID33251371

P2093author name stringShipra Bhati
P2860cites workDataWarrior: an open-source program for chemistry aware data visualization and analysisQ30882770
Mechanisms and enzymes involved in SARS coronavirus genome expressionQ31153826
Ambit-SMIRKS: a software module for reaction representation, reaction search and structure transformationQ56247660
P433issue11
P921main subjectCOVID-19Q84263196
P304page(s)e05558
P577publication date2020-11-20
P1433published inHeliyonQ27727019
P1476titleStructure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19
P478volume6

Search more.